A meta‐analysis assessing the prevalence of drug–drug interactions among hospitalized patients
Pharmacoepidemiology and Drug Safety · 2023-12 · 32 (12) · 1319-1330
DOI: 10.1002/pds.5691 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 13.09.2023. Verfasst von Nilay Aksoy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Faculty of Pharmacy, Altınbaş University, İstanbul, Turkey. Hauptthemen laut MEDLINE: Hospitalization, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Purpose
Drug–drug interactions (DDIs), particularly in hospitalized patients can result in adverse drug events and unfavorable health consequences. The aim of this meta‐analysis is to provide up‐to‐date evidence on the prevalence of clinically evident adverse drug events due to DDIs in hospitalized patients.
Methods
Data from Scopus, PubMed, Cochrane and Web of Science were extracted using these keywords (Drug interaction/drug–drug interactions, Hospital/ hospitals, Adverse drug event, Hospitalized patients, inpatient, Department, Hospital stay, Harm, Mortality, death). The studies that include Observational studies on hospitalized patients, reporting potential DDIs using an electronic database, and reporting the clinically observed adverse drug interactions (ADI) through symptoms, signs or Laboratory tests are included. Using Open meta‐Software (version 12.11.14), the incidence of clinically evident DDIs among hospitalized patients was determined and shown in a forest plot.
Results
Only 15 of the 8261 articles found through a literature search met the inclusion criteria and reported the desired outcome. The pooled prevalence of potential drug–drug interactions is 64.9% (CI 95% 0.618–0.736). While clinically evident DDIs have a pooled frequency of 17.17% (CI 95% 0.133–0.256).
Conclusion
The issue of DDIs remains a significant concern in hospitalized patients, with a notable rise in their prevalence. This meta‐analysis encompassed a greater quantity of studies and demonstrated a heightened proportion of drug–drug interaction prevalence in comparison to the percentages reported in the previously published meta‐analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Faculty of Pharmacy, Altınbaş University, İstanbul, Turkey.
- Department of Clinical Pharmacy, Graduate School of Health Sciences, İstanbul Medipol University, İstanbul, Turkey.
ORCID-Profile: Nilay Aksoy, Nur Ozturk
Zitieren
APA
Aksoy, N., & Ozturk, N. (2023). A meta‐analysis assessing the prevalence of drug–drug interactions among hospitalized patients. Pharmacoepidemiology and Drug Safety, 32(12), 1319-1330. https://doi.org/10.1002/pds.5691
Vancouver
Aksoy N, Ozturk N. A meta‐analysis assessing the prevalence of drug–drug interactions among hospitalized patients. Pharmacoepidemiology and Drug Safety. 2023;32(12):1319-1330. doi:10.1002/pds.5691
BibTeX
@article{Aksoy2023,
author = {Aksoy, Nilay and Ozturk, Nur},
title = {A meta‐analysis assessing the prevalence of drug–drug interactions among hospitalized patients},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2023},
volume = {32},
number = {12},
pages = {1319--1330},
doi = {10.1002/pds.5691}
}
EUVIMED